` OIL (Optiscan Imaging Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

OIL
vs
S
S&P/ASX 300

Over the past 12 months, OIL has underperformed S&P/ASX 300, delivering a return of -40% compared to the S&P/ASX 300's +6% growth.

Stocks Performance
OIL vs S&P/ASX 300

Loading
OIL
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
OIL vs S&P/ASX 300

Performance Gap Between OIL and AXKO
HIDDEN
Show

Performance By Year
OIL vs S&P/ASX 300

Loading
OIL
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Optiscan Imaging Ltd vs Peers

S&P/ASX 300
OIL
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Optiscan Imaging Ltd
Glance View

Market Cap
109.6m AUD
Industry
Health Care

Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The company is headquartered in Mulgrave, Victoria. The firm has developed and commercialized confocal microscopes for clinical and pre-clinical applications. Its endomicroscopic technology enables 3D, in-vivo imaging of human tissue at the cellular level for cancer screening, diagnoses and in surgery. Its InVivage device is developed for clinical use in the oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a miniaturised confocal endomicroscope used for cellular level in-vivo imaging in living tissues. The firm also provides customization options for its product, (FIVE2).

OIL Intrinsic Value
HIDDEN
Show
Back to Top